Rotavirus Vaccine Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032
CHAPTER 1. Industry Overview of Rotavirus Vaccine Market
1.1. Definition and Scope
1.1.1. Definition of Rotavirus Vaccine
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Rotavirus Vaccine Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Rotavirus Vaccine Market By Type
1.2.3. Rotavirus Vaccine Market By End-Use
1.2.4. Rotavirus Vaccine Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Rotavirus Vaccine Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Rotavirus Vaccine Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Rotavirus Vaccine Market By Type
5.1. Introduction
5.2. Rotavirus Vaccine Revenue By Type
5.2.1. Rotavirus Vaccine Revenue (USD Million) and Forecast, By Type, 2020-2032
5.2.2. Lanzhou Lamb
5.2.2.1. Lanzhou Lamb Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Rotarix
5.2.3.1. Rotarix Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Rotavac
5.2.4.1. Rotavac Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Rotavin-M1
5.2.5.1. Rotavin-M1 Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.6. Others
5.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Rotavirus Vaccine Market By End-Use
6.1. Introduction
6.2. Rotavirus Vaccine Revenue By End-Use
6.2.1. Rotavirus Vaccine Revenue (USD Million) and Forecast, By End-Use, 2020-2032
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Clinics
6.2.3.1. Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Academic & Research Lab
6.2.4.1. Academic & Research Lab Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Rotavirus Vaccine Market By Country
7.1. North America Rotavirus Vaccine Market Overview
7.2. U.S.
7.2.1. U.S. Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
7.2.2. U.S. Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
7.3. Canada
7.3.1. Canada Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
7.3.2. Canada Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Rotavirus Vaccine Market By Country
8.1. Europe Rotavirus Vaccine Market Overview
8.2. U.K.
8.2.1. U.K. Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
8.2.2. U.K. Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
8.3. Germany
8.3.1. Germany Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
8.3.2. Germany Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
8.4. France
8.4.1. France Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
8.4.2. France Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
8.5. Spain
8.5.1. Spain Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
8.5.2. Spain Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
8.6.2. Rest of Europe Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Rotavirus Vaccine Market By Country
9.1. Asia Pacific Rotavirus Vaccine Market Overview
9.2. China
9.2.1. China Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
9.2.2. China Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.3. Japan
9.3.1. Japan Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
9.3.2. Japan Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.4. India
9.4.1. India Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
9.4.2. India Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.5. Australia
9.5.1. Australia Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
9.5.2. Australia Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.6. South Korea
9.6.1. South Korea Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
9.6.2. South Korea Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
9.7.2. Rest of Asia-Pacific Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Rotavirus Vaccine Market By Country
10.1. Latin America Rotavirus Vaccine Market Overview
10.2. Brazil
10.2.1. Brazil Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
10.2.2. Brazil Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
10.3. Mexico
10.3.1. Mexico Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
10.3.2. Mexico Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
10.4.2. Rest of Latin America Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Rotavirus Vaccine Market By Country
11.1. Middle East & Africa Rotavirus Vaccine Market Overview
11.2. GCC
11.2.1. GCC Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
11.2.2. GCC Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
11.3. South Africa
11.3.1. South Africa Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
11.3.2. South Africa Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Rotavirus Vaccine Revenue (USD Million) and Forecast By Type, 2020-2032
11.4.2. Rest of Middle East & Africa Rotavirus Vaccine Revenue (USD Million) and Forecast By End-Use, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Rotavirus Vaccine Market
12.1. Rotavirus Vaccine Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Rotavirus Vaccine Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. BIOVIRx Inc
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2023
13.1.3.2. BIOVIRx Inc 2023 Rotavirus Vaccine Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Serum Institute of India Pvt. Ltd.
13.3. Merck & Co., Inc.
13.4. Bharat Biotech
13.5. Biological E
13.6. Bio Farma
13.7. Novartis AG
13.8. GlaxoSmithKline plc.
13.9. Sanofi
13.10. Lanzhou Institute of Biologicals Products Co., Ltd
13.11. Berghofer Medical Research Institute
13.12. Pfizer, Inc.
Frequently Asked Questions
How big is the rotavirus vaccine market?
The rotavirus vaccine market size was valued at USD 10,819.1 million in 2023.
What is the CAGR of the global rotavirus vaccine market from 2024 to 2032?
The CAGR of rotavirus vaccine is 10.3% during the analysis period of 2024 to 2032.
Which are the key players in the rotavirus vaccine market?
The key players operating in the global market are including BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Bharat Biotech, Biological E, Bio Farma, Novartis AG, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, Berghofer Medical Research Institute, and Pfizer, Inc.
Which region dominated the global rotavirus vaccine market share?
North America held the dominating position in rotavirus vaccine industry during the analysis period of 2024 to 2032.
Which region registered fastest CAGR from 2024 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of rotavirus vaccine during the analysis period of 2024 to 2032.
What are the current trends and dynamics in the global rotavirus vaccine industry?
The current trends and dynamics in the rotavirus vaccine industry include increasing demand in construction and infrastructure sectors, growing emphasis on safety regulations and standards, adoption of rotavirus vaccines in automotive industry for vehicle design, and rise in disposable income and urbanization leading to higher consumer spending.
Which end-use held the maximum share in 2023?
The commercial end-use held the maximum share of the rotavirus vaccine industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
